NO20005920D0 - Mikroemulsjonsforkonsentrater som inneholder en piperidin stoff P antagonist - Google Patents

Mikroemulsjonsforkonsentrater som inneholder en piperidin stoff P antagonist

Info

Publication number
NO20005920D0
NO20005920D0 NO20005920A NO20005920A NO20005920D0 NO 20005920 D0 NO20005920 D0 NO 20005920D0 NO 20005920 A NO20005920 A NO 20005920A NO 20005920 A NO20005920 A NO 20005920A NO 20005920 D0 NO20005920 D0 NO 20005920D0
Authority
NO
Norway
Prior art keywords
antagonist
concentrates containing
microemulsion concentrates
piperidine substance
piperidine
Prior art date
Application number
NO20005920A
Other languages
English (en)
Other versions
NO20005920L (no
Inventor
Steffen Lang
Kurt Liechti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9811200.6A external-priority patent/GB9811200D0/en
Priority claimed from GBGB9818105.0A external-priority patent/GB9818105D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20005920D0 publication Critical patent/NO20005920D0/no
Publication of NO20005920L publication Critical patent/NO20005920L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005920A 1998-05-26 2000-11-23 Mikroemulsjons-forkonsentrater som inneholder en piperidinstoff-P-antagonist NO20005920L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9811200.6A GB9811200D0 (en) 1998-05-26 1998-05-26 Organic compounds
GBGB9818105.0A GB9818105D0 (en) 1998-08-19 1998-08-19 Organic compounds
PCT/EP1999/003623 WO1999061025A1 (en) 1998-05-26 1999-05-26 Microemulsion preconcentrates containing a piperidine substance p antagonist

Publications (2)

Publication Number Publication Date
NO20005920D0 true NO20005920D0 (no) 2000-11-23
NO20005920L NO20005920L (no) 2001-01-25

Family

ID=26313736

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005920A NO20005920L (no) 1998-05-26 2000-11-23 Mikroemulsjons-forkonsentrater som inneholder en piperidinstoff-P-antagonist

Country Status (30)

Country Link
US (2) US20020156099A1 (no)
EP (1) EP1082119B1 (no)
JP (1) JP4083985B2 (no)
KR (1) KR20010043669A (no)
CN (1) CN1270714C (no)
AR (1) AR018376A1 (no)
AT (1) ATE257380T1 (no)
AU (1) AU755134B2 (no)
BE (1) BE1012143A5 (no)
BR (1) BR9910696A (no)
CA (1) CA2333154C (no)
DE (2) DE69914077T2 (no)
DK (1) DK1082119T3 (no)
ES (1) ES2214859T3 (no)
FR (1) FR2779145B1 (no)
GB (1) GB2353473A (no)
HU (1) HUP0102202A3 (no)
ID (1) ID27096A (no)
IL (1) IL139501A0 (no)
IT (1) IT1313551B1 (no)
NO (1) NO20005920L (no)
NZ (1) NZ508325A (no)
PE (1) PE20000537A1 (no)
PL (1) PL344245A1 (no)
PT (1) PT1082119E (no)
RU (1) RU2240121C2 (no)
SK (1) SK17752000A3 (no)
TR (1) TR200003502T2 (no)
TW (1) TW537894B (no)
WO (1) WO1999061025A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW537894B (en) 1998-05-26 2003-06-21 Novartis Ag A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist
AU2003225260A1 (en) * 2002-04-22 2003-11-03 University Of Florida Microemulsions for selective molecular separation
GB0220953D0 (en) * 2002-09-10 2002-10-23 Novartis Ag Organic compounds
US7842791B2 (en) 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
FR2935001B1 (fr) * 2008-08-14 2011-12-30 Commissariat Energie Atomique Emulsion fluorescente
FR2934955B1 (fr) 2008-08-14 2011-07-08 Commissariat Energie Atomique Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
FR2934953B1 (fr) 2008-08-14 2011-01-21 Commissariat Energie Atomique Nanoemulsions de nanocristaux
FR2934954B1 (fr) 2008-08-14 2011-07-22 Commissariat Energie Atomique Emulsion fluorescente de vert d'indocyanine
SG11201505076UA (en) * 2012-12-31 2015-07-30 Jrx Biotechnology Inc Liquid topical pharmaceutical nano-emulsion formulations

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3305689A1 (de) 1983-02-18 1984-08-23 Mack Chem Pharm Pharmazeutische zubereitung mit retardwirkung
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
DE4220616C2 (de) 1992-06-24 1994-12-22 Byk Gulden Lomberg Chem Fab Dexniguldipin zur intravenösen Verabreichung
PT589843E (pt) 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
EP0788346B9 (en) * 1994-03-18 2007-02-14 Supernus Pharmaceuticals, Inc. Emulsified drug delivery systems
TW397825B (en) * 1994-10-14 2000-07-11 Novartis Ag Aroyl-piperidine derivatives
MY129435A (en) * 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
GB2308545B (en) 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
FR2728165A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2728169A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
KR19980703354A (ko) * 1995-03-27 1998-10-15 나카토미히로타카 피페리딘 유도체
NZ280689A (en) 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
GB9601120D0 (en) 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
WO1997045119A1 (en) 1996-05-24 1997-12-04 Novartis Ag Use of substance p antagonists for treating social phobia
TW537894B (en) 1998-05-26 2003-06-21 Novartis Ag A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist

Also Published As

Publication number Publication date
ES2214859T3 (es) 2004-09-16
SK17752000A3 (sk) 2001-05-10
ATE257380T1 (de) 2004-01-15
WO1999061025A1 (en) 1999-12-02
IT1313551B1 (it) 2002-09-09
JP4083985B2 (ja) 2008-04-30
AU4500899A (en) 1999-12-13
BE1012143A5 (fr) 2000-05-02
KR20010043669A (ko) 2001-05-25
NO20005920L (no) 2001-01-25
TR200003502T2 (tr) 2001-04-20
DE69914077D1 (de) 2004-02-12
CA2333154A1 (en) 1999-12-02
HK1035137A1 (en) 2001-11-16
US20030152626A1 (en) 2003-08-14
AR018376A1 (es) 2001-11-14
PT1082119E (pt) 2004-05-31
FR2779145A1 (fr) 1999-12-03
GB0028506D0 (en) 2001-01-10
JP2002516280A (ja) 2002-06-04
FR2779145B1 (fr) 2004-07-30
ID27096A (id) 2001-03-01
US20020156099A1 (en) 2002-10-24
TW537894B (en) 2003-06-21
CA2333154C (en) 2008-07-08
AU755134B2 (en) 2002-12-05
CN1303285A (zh) 2001-07-11
RU2240121C2 (ru) 2004-11-20
US6949257B2 (en) 2005-09-27
BR9910696A (pt) 2001-01-30
PE20000537A1 (es) 2000-07-10
EP1082119A1 (en) 2001-03-14
CN1270714C (zh) 2006-08-23
GB2353473A (en) 2001-02-28
NZ508325A (en) 2003-06-30
DE69914077T2 (de) 2004-06-09
HUP0102202A2 (hu) 2001-11-28
DK1082119T3 (da) 2004-04-13
IL139501A0 (en) 2001-11-25
PL344245A1 (en) 2001-10-08
HUP0102202A3 (en) 2003-01-28
DE19983247T1 (de) 2001-05-31
ITMI991164A1 (it) 2000-11-26
EP1082119B1 (en) 2004-01-07

Similar Documents

Publication Publication Date Title
IS5941A (is) Píperidín sem CCR5 stillar
DK0866117T3 (da) Mikroemulsion
EE200200588A (et) Bensoamiidpiperidiinühendid kui substants P antagonistid
NO993686D0 (no) Synkron-maskin
DE69826891D1 (de) Piperidinderivate
FIU20030476U0 (fi) Amlodipiinimaleaatti
ATE295916T1 (de) Modulare antiseismische vorrichtung zum schutz von gebäuden
PT1144411E (pt) Compostos espiro anti-histaminicos
PT1283838E (pt) Compostos de piperazina e de piperidina
NO20005920D0 (no) Mikroemulsjonsforkonsentrater som inneholder en piperidin stoff P antagonist
ID26451A (id) Panel lapisan sekali pakai buang
TR199900286A3 (tr) Pirolidin ve piperidin türevleri.
DE69831285D1 (de) Batteriebetriebene Baumaschine
ID29845A (id) Konsentrat oral sertralina
DE69821642D1 (de) Substituierte oxime als neurokinin antagonisten
ITVR20000025A1 (it) "solarium a pannello"
KR980001213U (ko) 철근 절단기
IT1317324B1 (it) Macchina per il fissaggio di coperchi a confezioni per fazzolettiumidificati, salviette o simili.
SI1082119T1 (en) Microemulsion preconcentrates containing a piperidine substance p antagonist
FI991617L (fi) Menetelmä vasteen tuottamiseksi
DE69817183D1 (de) Verkaufsautomat
DK1037892T3 (da) Piperidinderivater
NO20001778D0 (no) Substituerte piperidinderivater
FR2776692B1 (fr) Machine a platrer les plafonds
ID18802A (id) Mesin laminator adonan

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application